A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xinlu,Chai

第一单位： Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.

作者： Xinlu,Chai ^[1] ; Yuting,Meng ^[1] ; Wei,Ge ^[1] ; Juan,Wang ^[2] ; Fei,Li ^[3] ; Xue Jun,Wang ^[4] ; Xuerong,Wang ^[1]

作者单位： Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 210029, China. ^[1] Department of Pharmacology, Wannan Medical College, Wuhu, Anhui 241002, China. ^[2] Department of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 210029, China. ^[3] Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu 210029, China. ^[4]

关键词 H2O2-sensitive moiety gemcitabine non-small cell lung cancer thiazolidinone

DOI 10.7555/JBR.37.20230022

PMID 37705111

发布时间 2023-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of biomedical research

2023年37卷5期

355-366页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells.

Journal of biomedical research

相似文献

Journal of biomedical research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells.

Journal of biomedical research

相似文献

Journal of biomedical research

相关期刊

检索历史清除